| Name | Title | Contact Details |
|---|
Heart.com is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Hand & Stone is a 550-plus unit massage and facial spa franchise with a mission to bring affordable, luxury spa services to all. Launched in 2004, the company now has locations across 35 states and Canada. Hand & Stone offers its signature hot stone massage, along with other high-quality professional massage services such as Swedish, Himalayan Salt, Sports, Deep Tissue, Oncology and Prenatal. Guests can also visit the spa to enjoy best-in-class facial treatments performed by licensed estheticians. These feature top-of-the-line products backed by science, including Dermalogica and ClarityRx Clinical Skin Care. A wide range of services are available for women, men and teens and are tailored to each individual`s needs or skin concerns. The fastest-growing spa franchise in the country, Hand & Stone has been named No. 1 in the spa category by Entrepreneur Magazine in 2023, 2021 and 2020 and was ranked No. 8 on Forbes` Best Franchises to Buy list in the high investment category.
Manatee Diagnostic Ctr is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Bradenton, FL. To find more information about Manatee Diagnostic Ctr, please visit www.manateediagnostic.com
Ulrich Medical Concepts is a Paducah, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery primarily in the United States. Its lead therapeutic product candidate, HuCNS-SC cells (purified human neural stem cells), is in development as a potential treatment for a range of central nervous system disorders. The company has conducted a Phase I clinical trial in Pelizaeus-Merzbacher disease, a fatal myelination disorder in children. It is also conducting a Phase I/II clinical trial in chronic spinal cord injury; and has initiated a Phase I/II clinical trial in dry age-related macular degeneration, as well as is pursuing preclinical studies in Alzheimer’s disease. In addition, the company markets a rage of proprietary cell culture products, research grade human cells, and antibody reagents under the SC Proven brand. The proprietary cell culture products include iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff227, NDiff N2, and NDiff N27 supplements, as well as HEScGRO and ESGRO Complete; and antibody reagents comprise STEM24, STEM101, STEM121, and STEM123, which can be used for cell detection, isolation, and characterization. Further, StemCells is involved in developing and commercializing applications of its technologies to enable stem cell-based research. The company sells its tools and technologies products to researchers at academic institutions, pharmaceutical and biotechnology companies, and government laboratories. StemCells, Inc. was founded in 1988 and is headquartered in Newark, California.